Literature DB >> 22346447

Hepatitis C: Recent advances.

S D Shafran1, J M Conly.   

Abstract

Year:  1993        PMID: 22346447      PMCID: PMC3250799          DOI: 10.1155/1993/759254

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


× No keyword cloud information.
  35 in total

1.  Interferon and chronic non-A, non-B hepatitis: whom are we treating?

Authors:  R L Koretz
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

2.  Hepatitis C in hospital employees with needlestick injuries.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Nakano; S Furuta; K Nishioka; R H Purcell; H J Alter
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

3.  Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses.

Authors:  M S Urdea; T Horn; T J Fultz; M Anderson; J A Running; S Hamren; D Ahle; C A Chang
Journal:  Nucleic Acids Symp Ser       Date:  1991

4.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Ribavirin treatment for chronic hepatitis C.

Authors:  O Reichard; J Andersson; R Schvarcz; O Weiland
Journal:  Lancet       Date:  1991-05-04       Impact factor: 79.321

6.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

7.  The declining risk of post-transfusion hepatitis C virus infection.

Authors:  J G Donahue; A Muñoz; P M Ness; D E Brown; D H Yawn; H A McAllister; B A Reitz; K E Nelson
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

8.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

9.  Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.

Authors:  M Shindo; A M Di Bisceglie; J H Hoofnagle
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

10.  A pilot study of ribavirin therapy for chronic hepatitis C.

Authors:  A M Di Bisceglie; M Shindo; T L Fong; M W Fried; M G Swain; N V Bergasa; C A Axiotis; J G Waggoner; Y Park; J H Hoofnagle
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

View more
  1 in total

1.  Interferon-alpha in hepatitis C. Dosage, costs and benefits.

Authors:  A Briggs; A Shiell
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.